350 related articles for article (PubMed ID: 28204571)
21. In vitro interactions of micafungin with amphotericin B against clinical isolates of Candida spp.
Serena C; Mariné M; Quindós G; Carrillo AJ; Cano JF; Pastor FJ; Guarro J
Antimicrob Agents Chemother; 2008 Apr; 52(4):1529-32. PubMed ID: 18227181
[TBL] [Abstract][Full Text] [Related]
22. Activity of Combined Antifungal Agents Against Multidrug-Resistant Candida glabrata Strains.
Denardi LB; Keller JT; Oliveira V; Mario DAN; Santurio JM; Alves SH
Mycopathologia; 2017 Oct; 182(9-10):819-828. PubMed ID: 28493006
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetic/Pharmacodynamic Analysis of Isavuconazole Against Aspergillus spp. and Candida spp. in Healthy Subjects and Patients With Hepatic or Renal Impairment by Monte Carlo Simulation.
Zheng X; Xu G; Zhu L; Fang L; Zhang Y; Ding H; Tong Y; Sun J; Huang P
J Clin Pharmacol; 2018 Oct; 58(10):1266-1273. PubMed ID: 29762861
[TBL] [Abstract][Full Text] [Related]
24. Postantifungal Effect of Micafungin against the Species Complexes of Candida albicans and Candida parapsilosis.
Gil-Alonso S; Jauregizar N; Eraso E; Quindós G
PLoS One; 2015; 10(7):e0132730. PubMed ID: 26168269
[TBL] [Abstract][Full Text] [Related]
25. In Vitro Interaction of Geldanamycin with Triazoles and Echinocandins Against Common and Emerging Candida Species.
Mahmoudi S; Rezaie S; Daie Ghazvini R; Hashemi SJ; Badali H; Foroumadi A; Diba K; Chowdhary A; Meis JF; Khodavaisy S
Mycopathologia; 2019 Oct; 184(5):607-613. PubMed ID: 31401757
[TBL] [Abstract][Full Text] [Related]
26.
Schwarz P; Nikolskiy I; Bidaud AL; Sommer F; Bange G; Dannaoui E
Front Cell Infect Microbiol; 2022; 12():892893. PubMed ID: 35573795
[TBL] [Abstract][Full Text] [Related]
27. Isavuconazole: A new broad-spectrum azole. Part 1: In vitro activity.
Denis J; Ledoux MP; Nivoix Y; Herbrecht R
J Mycol Med; 2018 Mar; 28(1):8-14. PubMed ID: 29534853
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the Sensititre Yeast One microdilution method for susceptibility testing of Candida species to anidulafungin, caspofungin, and micafungin.
García-Agudo L; García-Martos P; Martos-Cañadas J; Aznar-Marín P; Marín-Casanova P; Rodríguez-Iglesias M
Rev Esp Quimioter; 2012 Dec; 25(4):256-60. PubMed ID: 23303256
[TBL] [Abstract][Full Text] [Related]
29. Susceptibility to echinocandins of Candida spp. strains isolated in Italy assessed by European Committee for Antimicrobial Susceptibility Testing and Clinical Laboratory Standards Institute broth microdilution methods.
Montagna MT; Lovero G; Coretti C; Martinelli D; De Giglio O; Iatta R; Balbino S; Rosato A; Caggiano G
BMC Microbiol; 2015 May; 15():106. PubMed ID: 25990252
[TBL] [Abstract][Full Text] [Related]
30. Multicenter Study of Method-Dependent Epidemiological Cutoff Values for Detection of Resistance in Candida spp. and Aspergillus spp. to Amphotericin B and Echinocandins for the Etest Agar Diffusion Method.
Espinel-Ingroff A; Arendrup M; Cantón E; Cordoba S; Dannaoui E; García-Rodríguez J; Gonzalez GM; Govender NP; Martin-Mazuelos E; Lackner M; Lass-Flörl C; Linares Sicilia MJ; Rodriguez-Iglesias MA; Pelaez T; Shields RK; Garcia-Effron G; Guinea J; Sanguinetti M; Turnidge J
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799206
[TBL] [Abstract][Full Text] [Related]
31. Antifungal efficacy of isavuconazole and liposomal amphotericin B in a rabbit model of Exserohilum rostratum meningoencephalitis: A preclinical paradigm for management of CNS phaeohyphomycosis.
Petraitis V; Petraitiene R; Katragkou A; Maung BBW; Moradi PW; Sussman-Straus GE; Naing E; Kovanda LL; Finkelman MA; Walsh TJ
Med Mycol; 2021 Feb; 59(2):189-196. PubMed ID: 33313821
[TBL] [Abstract][Full Text] [Related]
32. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
[TBL] [Abstract][Full Text] [Related]
33. In vitro activity of isavuconazole against clinically isolated yeasts from Chile.
Álvarez Duarte E; Salas V
Braz J Microbiol; 2020 Dec; 51(4):1801-1805. PubMed ID: 32638272
[TBL] [Abstract][Full Text] [Related]
34. In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms.
Katragkou A; McCarthy M; Alexander EL; Antachopoulos C; Meletiadis J; Jabra-Rizk MA; Petraitis V; Roilides E; Walsh TJ
J Antimicrob Chemother; 2015 Feb; 70(2):470-8. PubMed ID: 25288679
[TBL] [Abstract][Full Text] [Related]
35. Effect of 50% human serum on the killing activity of micafungin against eight Candida species using time-kill methodology.
Földi R; Szilágyi J; Kardos G; Berényi R; Kovács R; Majoros L
Diagn Microbiol Infect Dis; 2012 Aug; 73(4):338-42. PubMed ID: 22726529
[TBL] [Abstract][Full Text] [Related]
36. In vitro antifungal activity of FK463, a new water-soluble echinocandin-like lipopeptide.
Mikamo H; Sato Y; Tamaya T
J Antimicrob Chemother; 2000 Sep; 46(3):485-7. PubMed ID: 10980180
[TBL] [Abstract][Full Text] [Related]
37. Characterising the post-antifungal effects of micafungin against Candida albicans, Candida glabrata, Candida parapsilosis and Candida krusei isolates.
Nguyen KT; Ta P; Hoang BT; Cheng S; Hao B; Nguyen MH; Clancy CJ
Int J Antimicrob Agents; 2010 Jan; 35(1):80-4. PubMed ID: 19889519
[TBL] [Abstract][Full Text] [Related]
38. Antifungal activity of micafungin against Candida and Aspergillus spp. isolated from pediatric patients in Japan.
Ikeda F; Saika T; Sato Y; Suzuki M; Hasegawa M; Mikawa T; Kobayashi I; Tsuji A
Med Mycol; 2009 Mar; 47(2):145-8. PubMed ID: 18668422
[TBL] [Abstract][Full Text] [Related]
39. Activities of triazole-echinocandin combinations against Candida species in biofilms and as planktonic cells.
Chatzimoschou A; Katragkou A; Simitsopoulou M; Antachopoulos C; Georgiadou E; Walsh TJ; Roilides E
Antimicrob Agents Chemother; 2011 May; 55(5):1968-74. PubMed ID: 21343465
[TBL] [Abstract][Full Text] [Related]
40. Postantifungal effect of the combination of caspofungin with voriconazole and amphotericin B against clinical Candida krusei isolates.
Oz Y; Kiremitci A; Dag I; Metintas S; Kiraz N
Med Mycol; 2013 Jan; 51(1):60-5. PubMed ID: 22746405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
